AI-Powered Syrup Cap Inspection
Industry : Pharma
Summary: Defects in syrup caps lead to significant challenges for pharma companies, impacting multiple aspects of their operations. Additionally, regulatory risks become more prominent, as undetected defects can lead to non-compliance, fines, or even recalls. Pharma manufacturers can now leverage the SwitchOn DeepInspect® system to detect surface defects on syrup caps with an impressive 99.95% accuracy, ensuring superior product quality.
USE CASE
Impact
Following the implementation of DeepInspect, pharma manuacturers can experience significant improvements in their operations
Curious to Know More?
Download the full case study and explore how pharma manufacturers can leverage DeepInpsect to achieve zero defect lines